Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-15

Clinical Trial Update: DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for DS-6157a in advanced gastrointestinal stromal tumors has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DS-6157a

Snippet

Sponsor: Daiichi Sankyo | Conditions: Gastrointestinal Stromal Tumors | Phase 1 | Status: TERMINATED | Results posted: 2024-02-15